Previous 10 | Next 10 |
Icon (NASDAQ:ICLR) is scheduled to announce Q1 earnings results on Thursday, April 28th, before market open. The consensus EPS Estimate is $2.69 (+30.6% Y/Y) and the consensus Revenue Estimate is $1.89B (+120.2% Y/Y). Over the last 2 years, ICLR has beaten EPS estimates 63% of the time and ha...
ABG,ABMD,AEP,AIT,ALNY,AOS,ARES,ASPN,ASPS,ASX,OTCPK:ATGFF,BAX,BC,BCS,BFH,BTU,CARR,CAT,OTCPK:CDUAF,CFR,CG,CHD,CMCSA,CNX,CRS,CVAC,CWT,CX,CYBE,DPZ,DTE,EME,ERJ,FAF,FBP,FCN,FCNCA,FLWS,OTCQB:FMCC,FTV,GLOP,GLYC,GOL,GTX,GVA,GWW,HSY,HUN,HZO,ICLR,IP,IPG,IRM,JKS,KBR,KDP,KEX,KIM,LAZ,LECO,LH,LIN,LKQ,LLNW,L...
The shares of the Medpace Holdings (NASDAQ:MEDP) have reached a 52-week low on Tuesday after the contract research organization set the 2022 outlook unchanged despite its 1Q 2022 financials that stood above Street forecasts. The peers in the subsector, including ICON (ICLR), IQVIA Holdin...
Wells Fargo has downgraded life sciences company Thermo Fisher Scientific (NYSE:TMO) to underweight and lowered the price target from $605 to $525, citing an expensive valuation and "material headwinds for the stock ahead". Thermo Fisher (TMO) is trading -4.37% currently and -1...
The shares of Syneos Health (NASDAQ:SYNH) have recorded the worst intraday performance in over two years to reach a 52-week low after Jefferies downgraded the life sciences company to Hold from Buy citing risks to 2022 guidance. Supporting the thesis, the analysts led by David Windley point o...
ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. A sharp spike in bond yields pressured growth stocks and ...
Despite the recent weakness in contract research organizations, Deutsche Bank opts to take a favorable view on the subsector, citing industry checks. With stocks down 20 – 30% from the November peak and several names hovering near S&P market multiples, “we find the entry poi...
Medpace Holdings is a healthy business trading at a discount to its intrinsic value. Price target $193-200. The company has zero debt vs peer group average of $5.6B debt. Lower risk of permanent loss of capital vs peers. Medpace top-line in the past four years grew at 17.5% CAGR v...
BAMCO’s 13F portfolio value increased from $44.15B to $47.14B this quarter. Ron Baron increased Taiwan Semi, Iridium Communications, and Spotify while dropping Zillow Group. Their top five positions are at ~27% of the overall portfolio. For further details see: Tr...
ICON plc , (NASDAQ:ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that it will provide a live webcast of its Analyst Day meeting which will take place on Thursday, March 17, 2022 in Blue Bell, Philadelphia, starting at 12.30pm ET. T...
News, Short Squeeze, Breakout and More Instantly...
Highlights Net business wins in the quarter of $2,579 million, an increase of 6.6% on quarter two 2023. Reflects a net book to bill in the quarter of 1.22, and a trailing twelve month net book to bill of 1.24. Closing backlog of $23.8 billion, an increase of 2.0% on quarter one 20...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that all resolutions at the Annual General Meeting of the company (AGM) held on July 23, 2024 were duly passed by shareholders. ICON also confirmed that following the conclus...
ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2024 with a number of leading business and industry awards recognising the company’s leadership position in the clinical research industry, in addi...